Human iPSC and ESC translation potential debated

Fox, Jeffrey L.
May 2011
Nature Biotechnology;May2011, Vol. 29 Issue 5, p375
Academic Journal
The article focuses on a debate on the translation and commercialization of stem cell therapies using human induced pluripotent stem cells (iPSCs) and human embryonic stem cells (ESCs) in the U.S. It recalls a workshop held in Bethesda, Maryland in March 2011 where participants discussed the challenges and issues facing stem cell therapies. It notes that stem cell studies are being supported and regulated by federal programs. One safety concern regarding iPSCs mentioned is the risk of teratoma in patients transplanted with cells derived from ESC or iPSC.


Related Articles

  • SAJBL: Flagship special stem cell edition. Pepper, Michael S. // South African Journal of Bioethics & Law;2015 Supplement, Vol. 8, p2 

    An introduction is presented in which the guest editor discusses various reports within the issue on topics including human tissue and stem cell legislation, pluripotent stem cells and stem cell tourism in South Africa.

  • Stem cell therapy: A novel & futuristic treatment modality for disaster injuries. Gurudutta, G. U.; Satija, Neeraj Kumar; Singh, Vimal Kishor; Verma, Yogesh Kumar; Gupta, Pallavi; Tripathi, R. P // Indian Journal of Medical Research;Jan2012, Vol. 135 Issue 1, p15 

    Stem cell therapy hold the potential to meet the demand for transplant cells/tissues needed for treating damages resulting from both natural and man-made disasters. Pluripotency makes embryonic stem cells and induced pluripotent stem cells ideal for use, but their teratogenic character is a...

  • Stem Cell Reality Check. Sparks, Carley // Horse Sport;2013 Horse Health Annual, p28 

    The article investigates the science and science fiction of stem cell therapy. It provides a brief history of stem cell therapy beginning from the discovery of the two kinds of stem cells in bone marrows. Three types of stem cells, the embryonic stem cells, mesenchymal stem cells and induced...

  • Gene interaction studies in cellular reprogramming of adult stem cells to embyronic like stem cells. Gangadaran, Nishanthi; James, Jannet Vennila // Bioinformation;2012, Vol. 8 Issue 19, p912 

    The sophisticated process of reprogramming of adult stem cells to embryonic-like stem cells, known as cellular reprogramming, involves the risk of generation of tumorigenic cells due to the complexity involved. Oct4 protein is the inevitable element for inducing pluripotency along with Sox2 and...

  • The promise of induced pluripotent stem cells in research and therapy. Robinton, Daisy A.; Daley, George Q. // Nature;1/19/2012, Vol. 481 Issue 7381, p295 

    The field of stem-cell biology has been catapulted forward by the startling development of reprogramming technology. The ability to restore pluripotency to somatic cells through the ectopic co-expression of reprogramming factors has created powerful new opportunities for modelling human diseases...

  • Electrically Guiding Migration of Human Induced Pluripotent Stem Cells. Zhang, Jiaping; Calafiore, Marco; Zeng, Qunli; Zhang, Xiuzhen; Huang, Yuesheng; Li, Ronald; Deng, Wenbin; Zhao, Min // Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p987 

    A major road-block in stem cell therapy is the poor homing and integration of transplanted stem cells with the targeted host tissue. Human induced pluripotent stem (hiPS) cells are considered an excellent alternative to embryonic stem (ES) cells and we tested the feasibility of using small,...

  • A Comparison of Stem Cells for Therapeutic Use. Rodgerson, Denis; Harris, Alan // Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p782 

    A critical comparison of the attributes of several types of stem cells is presented, with particular emphasis on properties that are critical for the application of these cells for therapeutic purposes. The importance of an autologous source of pluripotent stem cells is stressed. It is apparent...

  • Stemming Our Irrational Exuberance. Brenner, Malcolm K. // Molecular Therapy;Aug2011, Vol. 19 Issue 8, p1399 

    The author reflects on the technique to generate human embryonic stem cells (hESCs) and inducible pluripotent stem cells (iPSCs). He says that hESCs and iPSCs are genetically modified and has a major benefit for almost every disease. An overview of the argument regarding the bond issue for the...

  • Applying Pluripotent Stem Cells in Drug Discovery. Steger, Matthias // Drug Discovery;2010, Vol. 7, p18 

    There is huge excitement around the potential of pluripotent stem cells in drug discovery. Human embryonic stem cells are proving to be a rich source of previously scarce cell types, such as cardiomyocytes, neurons and hepatocytes, for use in pre-clinical pharmaceutical research. For example, it...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics